Translation, Cross-Cultural Adaptation, and Psychometric Properties of the Revised Fibromyalgia Impact Questionnaire (FIQR) for Use in Arabic-Speaking Patients in Saudi Arabia
DOI: https://doi.org/10.2147/ppa.s452067
2024-05-27
Patient Preference and Adherence
Abstract:Shiekha S Alaujan, 1 Haya M Almalag, 1 Saja H Almazrou, 1 Nora A Alkhudair, 1 Faris A Alodaibi, 2 Mohammed A Omair 3 1 Clinical Pharmacy Department, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia; 2 Rehabilitation Sciences Department, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia; 3 Rheumatology Unit, Department of Medicine, King Saud University, Riyadh, Saudi Arabia Correspondence: Shiekha S Alaujan, Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, 11149, Saudi Arabia, Tel +966118054327, Email Background/Aim: Fibromyalgia (FM) is a complex and debilitating condition that significantly impacts patients' daily lives. The continuous assessment of the impact and severity of FM is essential to manage the condition effectively. Assessment tools in Arabic are lacking for use in Saudi Arabia, which might lead to ineffective management. This study aimed to translate and cross-culturally adapt and validate the Arabic version of the Revised Fibromyalgia Impact Questionnaire (FIQR). Methods: Following translation guidelines, 2 Arabic translators and 2 English-certified translators performed forward and backward translations of the FIQR. In a cross-sectional study design, the questionnaire was piloted with 5 participants and then subjected to cognitive interviews and psychometric analysis. Participants were FM patients recruited from a University Hospital in Riyadh and FM support groups in Saudi Arabia. The internal consistency, and reliability using the Cronbach α and interclass correlation coefficient (ICC) of 2-week test–retest, and criterion validity were evaluated. Results: The results included a total of 42 participants with FM. Six minor modifications were made during the stepwise translation of the questionnaire. The Arabic version of the FIQR had good internal consistency and test–retest reliability, with a Cronbach α of 0.855 for the physical functioning domain, 0.663 for overall well-being, 0.803 for symptoms, and 0.895 for the total FIQR, and the Pearson correlation coefficient of the ICC for physical functioning was 0.769 (95% confidence interval (CI), 0.541– 0.884) for the overall well-being domain, 0.555 (95% CI, 0.129– 0.772) for the symptoms domain, and 0.720 (95% CI, 0.370– 0.868) and 0.794 (95% CI, 0.579– 0.899) for the total FIQR score ( p < 0.001), respectively. Conclusion: The Arabic version of the FIQR is a valid, reliable, and practical tool for assessing the impact of FM on Arabic-speaking patients and potentially contributing to the improvement of FM outcomes. Keywords: translation, cross-cultural adaptation, validation, validation studies, fibromyalgia, Arabic Fibromyalgia (FM) is a chronic complex disorder characterized by widespread pain, fatigue, sleep disturbances, and cognitive dysfunction, affecting both the physical and mental well-being of patients who have no other reasons for pain lasting at least 3 months. 1,2 FM affects millions of people worldwide, and the global prevalence of FM ranges from 0.4% to 9.3% among the general population, with more women affected than men. 3 A systematic review found that FM affects 13.4% of the Saudi population. 4 Due to the debilitating nature of FM, it can significantly impair patients' quality of life and work productivity, 5,6 and it imposes a considerable economic, personal, and social burden. 7–9 In daily clinical practice, continuous assessment of the impact and severity of FM on patients is crucial for evaluating patients' status and treatment outcomes. Moreover, accurate assessment is key to guiding clinical decision-making and understanding the disorder's burden on patients and healthcare systems. The Fibromyalgia Impact Questionnaire (FIQ) is a condition-specific, self-reported instrument translated into more than 14 languages, and more than 300 research papers use it to assess the health status of patients with FM. 10 In 2009, Bennett et al introduced a revised version of the FIQ (FIQR) that overcomes the limitations of the FIQ and has a more comprehensive assessment of FM's impact. According to the Outcomes Measures in Rheumatoid Arthritis Clinical Trials (OMERACT) domains that should be assessed in FM trials, the FIQR is a patient-reported outcome measure (PROM) that covers the core and most of the peripheral domains that should be assessed in FM trials. 11 A systematic review published in 2023 found that 81.9% of 107 FM trials applied both versions of the FIQ as outcomes measures. 12 The revised version is strongly associated with the original FIQ and has excellent psychometric propertie -Abstract Truncated-
medicine, general & internal